Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

Gijs van Haaften; Gillian L. Dalgliesh; Helen Davies; Lina Chen; Graham R. Bignell; Chris Greenman; Sarah Edkins; Claire Hardy; Sarah O’Meara; Jon W. Teague; Adam P. Butler; Jonathan Hinton; Calli Latimer; J. M. Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J. Campbell; Jennifer Cole; Simon Forbes; Mingming Jia; David Jones; Chai Yin Kok; Catherine Leroy; Meng‐Lay Lin; David J. McBride; Mark Maddison; Simon Maquire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Erin Pleasance; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick Tarpey; R. James Turner; Kelly Turrell; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; V. Peter Collins; Koichi Ichimura; Simon Law; John B. Wong; Siu Tsan Yuen; Suet Yi Leung; Giovanni Tonon; Ronald A. DePinho; Yu‐Tzu Tai; Kenneth C. Anderson; Richard J. Kahnoski; Aaron Massie; Sok Kean Khoo; Bin Tean Teh; Michael R. Stratton; P. Andrew Futreal

doi:10.1038/ng.349

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

Gijs van Haaften(Wellcome Sanger Institute), Gillian L. Dalgliesh(Wellcome Sanger Institute), Helen Davies(Wellcome Sanger Institute), Lina Chen(Wellcome Sanger Institute), Graham R. Bignell(Wellcome Sanger Institute), Chris Greenman(Wellcome Sanger Institute), Sarah Edkins(Wellcome Sanger Institute), Claire Hardy(Wellcome Sanger Institute), Sarah O’Meara(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Jonathan Hinton(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), J. M. Andrews(Wellcome Sanger Institute), Syd Barthorpe(Wellcome Sanger Institute), Dave Beare(Wellcome Sanger Institute), Gemma Buck(Wellcome Sanger Institute), Peter J. Campbell(Wellcome Sanger Institute), Jennifer Cole(Wellcome Sanger Institute), Simon Forbes(Wellcome Sanger Institute), Mingming Jia(Wellcome Sanger Institute), David Jones(Wellcome Sanger Institute), Chai Yin Kok(Wellcome Sanger Institute), Catherine Leroy(Wellcome Sanger Institute), Meng‐Lay Lin(Wellcome Sanger Institute), David J. McBride(Wellcome Sanger Institute), Mark Maddison(Wellcome Sanger Institute), Simon Maquire(Wellcome Sanger Institute), Kirsten McLay(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Tatiana Mironenko(Wellcome Sanger Institute), Lee Mulderrig(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Erin Pleasance(Wellcome Sanger Institute), Rebecca Shepherd(Wellcome Sanger Institute), Raffaella Smith(Wellcome Sanger Institute), Lucy Stebbings(Wellcome Sanger Institute), Philip Stephens(Wellcome Sanger Institute), Gurpreet Tang(Wellcome Sanger Institute), Patrick Tarpey(Wellcome Sanger Institute), R. James Turner(Wellcome Sanger Institute), Kelly Turrell(Wellcome Sanger Institute), Jennifer Varian(Wellcome Sanger Institute), Sofie West(Wellcome Sanger Institute), Sara Widaa(Wellcome Sanger Institute), Paul Wray(Wellcome Sanger Institute), V. Peter Collins(University of Cambridge), Koichi Ichimura(University of Cambridge), Simon Law(University of Hong Kong), John B. Wong(Queen Mary Hospital), Siu Tsan Yuen(University of Hong Kong), Suet Yi Leung(Queen Mary Hospital), Giovanni Tonon(Dana-Farber Cancer Institute), Ronald A. DePinho(Dana-Farber Cancer Institute), Yu‐Tzu Tai(Dana-Farber Cancer Institute), Kenneth C. Anderson(Dana-Farber Cancer Institute), Richard J. Kahnoski(Corewell Health Blodgett Hospital), Aaron Massie(Corewell Health Blodgett Hospital), Sok Kean Khoo(Cancer Genetics (United States)), Bin Tean Teh(Cancer Genetics (United States)), Michael R. Stratton(Institute of Cancer Research), P. Andrew Futreal(Wellcome Sanger Institute)

Nature Genetics

March 29, 2009

10.1038/ng.349

Cited by 788Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis